| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytidine deaminase activity | 2.10e-06 | 13 | 40 | 3 | GO:0004126 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.66e-05 | 25 | 40 | 3 | GO:0033691 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.53e-05 | 188 | 40 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | deaminase activity | 4.27e-05 | 34 | 40 | 3 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 5.08e-05 | 36 | 40 | 3 | GO:0016814 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 9.59e-05 | 120 | 40 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 5.23e-04 | 187 | 40 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 6.73e-04 | 200 | 40 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.30e-03 | 239 | 40 | 4 | GO:0031406 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.60e-03 | 430 | 40 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.63e-03 | 254 | 40 | 4 | GO:0043177 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.70e-03 | 257 | 40 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.79e-03 | 654 | 40 | 6 | GO:0008233 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.98e-03 | 268 | 40 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | fibronectin binding | 2.63e-03 | 38 | 40 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 3.10e-03 | 146 | 40 | 3 | GO:0016810 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 3.35e-03 | 310 | 40 | 4 | GO:0030246 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.88e-03 | 323 | 40 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.69e-03 | 51 | 40 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 4.77e-03 | 1353 | 40 | 8 | GO:0004888 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 5.57e-03 | 180 | 40 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | protease binding | 5.66e-03 | 181 | 40 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | heparin binding | 6.66e-03 | 192 | 40 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 7.55e-03 | 201 | 40 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | zinc ion binding | 8.14e-03 | 891 | 40 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.09e-02 | 435 | 40 | 4 | GO:0004857 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A ADAMTSL1 ADAMTS9 ADAMTSL4 LPA | 3.43e-08 | 377 | 40 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A ADAMTSL1 ADAMTS9 ADAMTSL4 LPA | 3.51e-08 | 378 | 40 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A ADAMTSL1 ADAMTS9 ADAMTSL4 LPA | 3.59e-08 | 379 | 40 | 9 | GO:0045229 |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.35e-07 | 6 | 40 | 3 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.35e-07 | 6 | 40 | 3 | GO:0099046 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 8.03e-07 | 10 | 40 | 3 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 1.47e-06 | 12 | 40 | 3 | GO:0016554 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 2.42e-06 | 14 | 40 | 3 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 2.42e-06 | 14 | 40 | 3 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 2.42e-06 | 14 | 40 | 3 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 2.42e-06 | 14 | 40 | 3 | GO:0045006 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 3.72e-06 | 16 | 40 | 3 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 3.72e-06 | 16 | 40 | 3 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 3.72e-06 | 16 | 40 | 3 | GO:0046133 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 5.40e-06 | 18 | 40 | 3 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 6.41e-06 | 19 | 40 | 3 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 6.41e-06 | 19 | 40 | 3 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 7.53e-06 | 20 | 40 | 3 | GO:0039692 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 1.70e-05 | 26 | 40 | 3 | GO:0042454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 1.91e-05 | 27 | 40 | 3 | GO:0006213 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.08e-05 | 817 | 40 | 9 | GO:0048514 | |
| GeneOntologyBiologicalProcess | DNA modification | 2.92e-05 | 31 | 40 | 3 | GO:0006304 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.00e-05 | 92 | 40 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 3.22e-05 | 32 | 40 | 3 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 3.22e-05 | 32 | 40 | 3 | GO:0009164 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 3.65e-05 | 5 | 40 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | ADAMTS16 EPOR SEMA5A ADGRF5 THBS1 THSD7A MDK ADAMTS9 LPA NOTCH4 | 4.23e-05 | 1125 | 40 | 10 | GO:0035239 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 5.02e-05 | 37 | 40 | 3 | GO:0034656 | |
| GeneOntologyBiologicalProcess | blood vessel development | 5.68e-05 | 929 | 40 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | pigment cell differentiation | 6.35e-05 | 40 | 40 | 3 | GO:0050931 | |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 6.84e-05 | 41 | 40 | 3 | GO:1901658 | |
| GeneOntologyBiologicalProcess | positive regulation of pigment cell differentiation | 7.65e-05 | 7 | 40 | 2 | GO:0050942 | |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 7.65e-05 | 7 | 40 | 2 | GO:0045634 | |
| GeneOntologyBiologicalProcess | vasculature development | 7.87e-05 | 969 | 40 | 9 | GO:0001944 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 9.68e-05 | 46 | 40 | 3 | GO:0072529 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 9.68e-05 | 46 | 40 | 3 | GO:0010526 | |
| GeneOntologyBiologicalProcess | branching involved in blood vessel morphogenesis | 1.03e-04 | 47 | 40 | 3 | GO:0001569 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 1.10e-04 | 48 | 40 | 3 | GO:0009119 | |
| GeneOntologyBiologicalProcess | retrotransposition | 1.10e-04 | 48 | 40 | 3 | GO:0032197 | |
| GeneOntologyBiologicalProcess | transposition | 1.24e-04 | 50 | 40 | 3 | GO:0032196 | |
| GeneOntologyBiologicalProcess | artery development | 1.26e-04 | 133 | 40 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 1.31e-04 | 9 | 40 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 1.31e-04 | 9 | 40 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 1.31e-04 | 9 | 40 | 2 | GO:0050932 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 1.47e-04 | 420 | 40 | 6 | GO:0045765 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 1.67e-04 | 430 | 40 | 6 | GO:1901342 | |
| GeneOntologyBiologicalProcess | negative regulation of viral genome replication | 1.74e-04 | 56 | 40 | 3 | GO:0045071 | |
| GeneOntologyBiologicalProcess | developmental pigmentation | 1.94e-04 | 58 | 40 | 3 | GO:0048066 | |
| GeneOntologyBiologicalProcess | tube development | ADAMTS16 EPOR SEMA5A ADGRF5 THBS1 THSD7A MDK ADAMTS9 LPA NOTCH4 | 2.63e-04 | 1402 | 40 | 10 | GO:0035295 |
| GeneOntologyBiologicalProcess | nucleoside metabolic process | 3.10e-04 | 68 | 40 | 3 | GO:0009116 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 3.29e-04 | 14 | 40 | 2 | GO:0051918 | |
| GeneOntologyBiologicalProcess | angiogenesis | 3.78e-04 | 708 | 40 | 7 | GO:0001525 | |
| GeneOntologyBiologicalProcess | regulation of developmental pigmentation | 3.79e-04 | 15 | 40 | 2 | GO:0048070 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression via chromosomal CpG island demethylation | 3.79e-04 | 15 | 40 | 2 | GO:0044029 | |
| GeneOntologyBiologicalProcess | regulation of pigmentation | 4.90e-04 | 17 | 40 | 2 | GO:0120305 | |
| GeneOntologyBiologicalProcess | regulation of artery morphogenesis | 4.90e-04 | 17 | 40 | 2 | GO:1905651 | |
| GeneOntologyBiologicalProcess | epithelial cell apoptotic process | 5.12e-04 | 192 | 40 | 4 | GO:1904019 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 5.19e-04 | 81 | 40 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 5.74e-04 | 198 | 40 | 4 | GO:0048754 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 6.14e-04 | 19 | 40 | 2 | GO:0051917 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 7.29e-04 | 91 | 40 | 3 | GO:0045069 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 7.53e-04 | 92 | 40 | 3 | GO:0072527 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 7.54e-04 | 375 | 40 | 5 | GO:0007162 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 7.77e-04 | 93 | 40 | 3 | GO:1903036 | |
| GeneOntologyBiologicalProcess | positive regulation of angiogenesis | 8.52e-04 | 220 | 40 | 4 | GO:0045766 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 8.52e-04 | 96 | 40 | 3 | GO:1901657 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculature development | 8.96e-04 | 223 | 40 | 4 | GO:1904018 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 1.04e-03 | 103 | 40 | 3 | GO:0048525 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.11e-03 | 236 | 40 | 4 | GO:0061138 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 1.16e-03 | 26 | 40 | 2 | GO:2001026 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage chemotaxis | 1.16e-03 | 26 | 40 | 2 | GO:0010759 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 1.44e-03 | 29 | 40 | 2 | GO:0042730 | |
| GeneOntologyBiologicalProcess | melanocyte differentiation | 1.44e-03 | 29 | 40 | 2 | GO:0030318 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.47e-03 | 1442 | 40 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.53e-03 | 258 | 40 | 4 | GO:0001763 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 1.65e-03 | 31 | 40 | 2 | GO:1900048 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 1.65e-03 | 31 | 40 | 2 | GO:0030194 | |
| GeneOntologyBiologicalProcess | negative regulation of sprouting angiogenesis | 1.75e-03 | 32 | 40 | 2 | GO:1903671 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 1.79e-03 | 269 | 40 | 4 | GO:0010594 | |
| GeneOntologyBiologicalProcess | pigmentation | 1.82e-03 | 125 | 40 | 3 | GO:0043473 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage migration | 1.86e-03 | 33 | 40 | 2 | GO:1905523 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.86e-03 | 126 | 40 | 3 | GO:1903035 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 1.98e-03 | 34 | 40 | 2 | GO:0050820 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 2.05e-03 | 694 | 40 | 6 | GO:0002694 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 2.10e-03 | 35 | 40 | 2 | GO:0035767 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.23e-03 | 286 | 40 | 4 | GO:0007188 | |
| GeneOntologyBiologicalProcess | regulation of macrophage chemotaxis | 2.34e-03 | 37 | 40 | 2 | GO:0010758 | |
| GeneOntologyBiologicalProcess | viral genome replication | 2.37e-03 | 137 | 40 | 3 | GO:0019079 | |
| GeneOntologyBiologicalProcess | macrophage activation | 2.52e-03 | 140 | 40 | 3 | GO:0042116 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 2.87e-03 | 41 | 40 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell migration | 2.94e-03 | 148 | 40 | 3 | GO:0010595 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | 3.15e-03 | 756 | 40 | 6 | GO:0050865 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell apoptotic process | 3.17e-03 | 152 | 40 | 3 | GO:1904035 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 3.35e-03 | 320 | 40 | 4 | GO:0002274 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 3.42e-03 | 156 | 40 | 3 | GO:1903900 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 3.46e-03 | 323 | 40 | 4 | GO:1901136 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN THBS1 MUC5B ADAMTSL1 MDK ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON LPA | 8.55e-12 | 656 | 40 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN THBS1 MUC5B ADAMTSL1 MDK ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON LPA | 8.91e-12 | 658 | 40 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 ADAMTS20 PAPLN THBS1 ADAMTSL1 MDK ADAMTS9 SSPOP ADAMTSL4 SBSPON LPA | 2.98e-09 | 530 | 40 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | cell surface | EPOR ADGRF5 THBS1 CD22 ADAMTS9 CRLF2 CLEC4C LPA NOTCH4 UNC5C | 3.39e-05 | 1111 | 40 | 10 | GO:0009986 |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 2.16e-04 | 61 | 40 | 3 | GO:0101003 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 3.68e-04 | 73 | 40 | 3 | GO:0070821 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.26e-04 | 519 | 40 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | P-body | 9.77e-04 | 102 | 40 | 3 | GO:0000932 | |
| MousePheno | abnormal conjunctival epithelium morphology | 5.45e-07 | 7 | 36 | 3 | MP:0004481 | |
| MousePheno | abnormal conjunctiva morphology | 4.41e-06 | 13 | 36 | 3 | MP:0001310 | |
| MousePheno | abnormal conjunctiva goblet cell morphology | 3.86e-05 | 4 | 36 | 2 | MP:0012164 | |
| MousePheno | abnormal eosinophil differentiation | 3.86e-05 | 4 | 36 | 2 | MP:0002443 | |
| MousePheno | respiratory system inflammation | 2.34e-04 | 220 | 36 | 5 | MP:0002405 | |
| MousePheno | abnormal cornea morphology | 3.10e-04 | 366 | 36 | 6 | MP:0001312 | |
| MousePheno | decreased susceptibility to Ortervirales infection | 4.19e-04 | 12 | 36 | 2 | MP:0020920 | |
| MousePheno | increased susceptibility to Retroviridae infection | 4.19e-04 | 12 | 36 | 2 | MP:0020934 | |
| MousePheno | decreased susceptibility to Retroviridae infection | 4.19e-04 | 12 | 36 | 2 | MP:0020935 | |
| MousePheno | abnormal eosinophil cell number | 4.61e-04 | 255 | 36 | 5 | MP:0002602 | |
| MousePheno | increased susceptibility to Ortervirales infection | 4.94e-04 | 13 | 36 | 2 | MP:0020919 | |
| MousePheno | abnormal eosinophil morphology | 5.04e-04 | 260 | 36 | 5 | MP:0005061 | |
| MousePheno | abnormal immune serum protein physiology | THBS1 MUC5B APOBEC3D RNF168 CD22 MUC5AC CRLF2 CLEC4C LPA APOBEC3F | 5.29e-04 | 1165 | 36 | 10 | MP:0002723 |
| Domain | TSP_1 | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ISM2 ADAMTS9 SSPOP ADAMTSL4 SBSPON UNC5C | 5.18e-28 | 63 | 40 | 15 | PF00090 |
| Domain | TSP1 | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ISM2 ADAMTS9 SSPOP ADAMTSL4 SBSPON UNC5C | 8.78e-28 | 65 | 40 | 15 | SM00209 |
| Domain | TSP1_rpt | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ISM2 ADAMTS9 SSPOP ADAMTSL4 SBSPON UNC5C | 8.78e-28 | 65 | 40 | 15 | IPR000884 |
| Domain | TSP1 | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ISM2 ADAMTS9 SSPOP ADAMTSL4 SBSPON UNC5C | 8.78e-28 | 65 | 40 | 15 | PS50092 |
| Domain | ADAM_spacer1 | 6.41e-12 | 23 | 40 | 6 | IPR010294 | |
| Domain | ADAM_spacer1 | 6.41e-12 | 23 | 40 | 6 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 8.53e-12 | 24 | 40 | 6 | IPR013273 | |
| Domain | PLAC | 6.86e-11 | 14 | 40 | 5 | PF08686 | |
| Domain | PLAC | 3.95e-10 | 19 | 40 | 5 | IPR010909 | |
| Domain | PLAC | 3.95e-10 | 19 | 40 | 5 | PS50900 | |
| Domain | IGc2 | 3.03e-08 | 235 | 40 | 8 | SM00408 | |
| Domain | Ig_sub2 | 3.03e-08 | 235 | 40 | 8 | IPR003598 | |
| Domain | - | CEACAM16 SIGLEC14 EPOR SIGLEC5 PAPLN ADGRF5 ADAMTSL1 CD22 CRLF2 UNC5C | 9.60e-07 | 663 | 40 | 10 | 2.60.40.10 |
| Domain | VWFC_1 | 1.01e-06 | 36 | 40 | 4 | PS01208 | |
| Domain | VWC | 1.26e-06 | 38 | 40 | 4 | SM00214 | |
| Domain | VWFC_2 | 1.26e-06 | 38 | 40 | 4 | PS50184 | |
| Domain | Peptidase_M12B_N | 1.41e-06 | 39 | 40 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.41e-06 | 39 | 40 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.56e-06 | 40 | 40 | 4 | PS00427 | |
| Domain | ADAM_MEPRO | 1.56e-06 | 40 | 40 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.56e-06 | 40 | 40 | 4 | PS50214 | |
| Domain | Reprolysin | 1.56e-06 | 40 | 40 | 4 | PF01421 | |
| Domain | Peptidase_M12B | 1.56e-06 | 40 | 40 | 4 | IPR001590 | |
| Domain | Ig-like_fold | CEACAM16 SIGLEC14 EPOR SIGLEC5 PAPLN ADGRF5 ADAMTSL1 CD22 CRLF2 UNC5C | 1.69e-06 | 706 | 40 | 10 | IPR013783 |
| Domain | Disintegrin_dom | 1.72e-06 | 41 | 40 | 4 | IPR001762 | |
| Domain | VWF_dom | 1.90e-06 | 42 | 40 | 4 | IPR001007 | |
| Domain | APOBEC_N | 1.98e-06 | 12 | 40 | 3 | PF08210 | |
| Domain | TIL | 1.98e-06 | 12 | 40 | 3 | PF01826 | |
| Domain | APOBEC_N | 1.98e-06 | 12 | 40 | 3 | IPR013158 | |
| Domain | C8 | 1.98e-06 | 12 | 40 | 3 | PF08742 | |
| Domain | IG | 2.55e-06 | 421 | 40 | 8 | SM00409 | |
| Domain | Ig_sub | 2.55e-06 | 421 | 40 | 8 | IPR003599 | |
| Domain | Unchr_dom_Cys-rich | 2.56e-06 | 13 | 40 | 3 | IPR014853 | |
| Domain | C8 | 2.56e-06 | 13 | 40 | 3 | SM00832 | |
| Domain | Ig_I-set | 2.95e-06 | 190 | 40 | 6 | IPR013098 | |
| Domain | I-set | 2.95e-06 | 190 | 40 | 6 | PF07679 | |
| Domain | TIL_dom | 3.26e-06 | 14 | 40 | 3 | IPR002919 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 3.26e-06 | 14 | 40 | 3 | IPR016192 | |
| Domain | Pept_M12B_GON-ADAMTSs | 4.47e-06 | 2 | 40 | 2 | IPR012314 | |
| Domain | GON | 4.47e-06 | 2 | 40 | 2 | PF08685 | |
| Domain | GON | 4.47e-06 | 2 | 40 | 2 | PS51046 | |
| Domain | VWFD | 5.00e-06 | 16 | 40 | 3 | PS51233 | |
| Domain | VWD | 5.00e-06 | 16 | 40 | 3 | SM00216 | |
| Domain | VWF_type-D | 5.00e-06 | 16 | 40 | 3 | IPR001846 | |
| Domain | VWD | 5.00e-06 | 16 | 40 | 3 | PF00094 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 6.06e-06 | 17 | 40 | 3 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 6.06e-06 | 17 | 40 | 3 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 6.06e-06 | 17 | 40 | 3 | IPR016193 | |
| Domain | CTCK_1 | 7.26e-06 | 18 | 40 | 3 | PS01185 | |
| Domain | IG_LIKE | 7.90e-06 | 491 | 40 | 8 | PS50835 | |
| Domain | VWC_out | 8.61e-06 | 19 | 40 | 3 | SM00215 | |
| Domain | Ig-like_dom | 9.43e-06 | 503 | 40 | 8 | IPR007110 | |
| Domain | Cys_knot_C | 2.03e-05 | 25 | 40 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.03e-05 | 25 | 40 | 3 | PS01225 | |
| Domain | MetalloPept_cat_dom | 2.66e-05 | 81 | 40 | 4 | IPR024079 | |
| Domain | - | 2.66e-05 | 81 | 40 | 4 | 3.40.390.10 | |
| Domain | VWC | 2.87e-05 | 28 | 40 | 3 | PF00093 | |
| Domain | ZINC_PROTEASE | 5.63e-05 | 98 | 40 | 4 | PS00142 | |
| Domain | WxxW_domain | 6.67e-05 | 6 | 40 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 6.67e-05 | 6 | 40 | 2 | PF13330 | |
| Domain | Hirudin/antistatin | 9.33e-05 | 7 | 40 | 2 | IPR011061 | |
| Domain | Glyco_hormone_CN | 4.61e-04 | 15 | 40 | 2 | IPR006208 | |
| Domain | Cys_knot | 4.61e-04 | 15 | 40 | 2 | PF00007 | |
| Domain | Ig_2 | 5.10e-04 | 73 | 40 | 3 | PF13895 | |
| Domain | ig | 7.12e-04 | 190 | 40 | 4 | PF00047 | |
| Domain | Immunoglobulin | 7.12e-04 | 190 | 40 | 4 | IPR013151 | |
| Domain | CT | 1.01e-03 | 22 | 40 | 2 | SM00041 | |
| Domain | GPCR_2_secretin-like_CS | 2.40e-03 | 34 | 40 | 2 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.31e-03 | 40 | 40 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.31e-03 | 40 | 40 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 3.31e-03 | 40 | 40 | 2 | IPR001879 | |
| Domain | CYSTEINE_SWITCH | 3.48e-03 | 41 | 40 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 3.82e-03 | 43 | 40 | 2 | IPR001818 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 5.13e-03 | 50 | 40 | 2 | PS00650 | |
| Domain | 7tm_2 | 5.13e-03 | 50 | 40 | 2 | PF00002 | |
| Domain | Ig/MHC_CS | 6.85e-03 | 58 | 40 | 2 | IPR003006 | |
| Domain | GPCR_2-like | 7.32e-03 | 60 | 40 | 2 | IPR017981 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON NOTCH4 | 5.88e-27 | 68 | 34 | 15 | M27303 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP ADAMTSL4 SBSPON | 1.61e-23 | 39 | 34 | 12 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP ADAMTSL4 SBSPON | 1.61e-23 | 39 | 34 | 12 | MM15165 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON NOTCH4 | 9.21e-22 | 143 | 34 | 15 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON | 1.41e-21 | 109 | 34 | 14 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON | 1.84e-21 | 111 | 34 | 14 | M27416 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON NOTCH4 | 4.87e-18 | 250 | 34 | 15 | M27554 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B RNF168 THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON | 2.26e-07 | 1389 | 34 | 15 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A THBS1 MUC5B ADAMTSL1 THSD7B RNF168 THSD7A ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON | 4.96e-07 | 1475 | 34 | 15 | M19806 |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.21e-05 | 26 | 34 | 3 | M27483 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 1.18e-04 | 7 | 34 | 2 | MM15412 | |
| Pathway | REACTOME_MRNA_EDITING | 2.01e-04 | 9 | 34 | 2 | MM15445 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 6.63e-04 | 16 | 34 | 2 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 7.51e-04 | 17 | 34 | 2 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.15e-03 | 21 | 34 | 2 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.38e-03 | 23 | 34 | 2 | M556 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.68e-03 | 32 | 34 | 2 | M165 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 2.84e-03 | 33 | 34 | 2 | M277 | |
| Pubmed | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 ADAMTSL1 THSD7B THSD7A ISM2 ADAMTS9 SSPOP ADAMTSL4 | 1.22e-25 | 75 | 41 | 13 | 20637190 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 17562860 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 6.08e-09 | 4 | 41 | 3 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 6.08e-09 | 4 | 41 | 3 | 26253512 | |
| Pubmed | Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif. | 1.52e-08 | 5 | 41 | 3 | 20012521 | |
| Pubmed | Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. | 1.52e-08 | 5 | 41 | 3 | 24851906 | |
| Pubmed | Structure-guided analysis of the human APOBEC3-HIV restrictome. | 3.03e-08 | 6 | 41 | 3 | 24657093 | |
| Pubmed | APOBEC3 proteins mediate the clearance of foreign DNA from human cells. | 5.30e-08 | 7 | 41 | 3 | 20062055 | |
| Pubmed | An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. | 5.30e-08 | 7 | 41 | 3 | 11863358 | |
| Pubmed | APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. | 5.30e-08 | 7 | 41 | 3 | 16527742 | |
| Pubmed | 5.30e-08 | 7 | 41 | 3 | 21835787 | ||
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 24227842 | ||
| Pubmed | APOBEC proteins and intrinsic resistance to HIV-1 infection. | 8.48e-08 | 8 | 41 | 3 | 19038776 | |
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 19008196 | ||
| Pubmed | 1.70e-07 | 210 | 41 | 6 | 16537572 | ||
| Pubmed | 2.49e-07 | 11 | 41 | 3 | 12683974 | ||
| Pubmed | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. | 2.49e-07 | 11 | 41 | 3 | 22915799 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 3.32e-07 | 12 | 41 | 3 | 25770910 | |
| Pubmed | CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. | 4.31e-07 | 13 | 41 | 3 | 35921817 | |
| Pubmed | 8.42e-07 | 16 | 41 | 3 | 31669249 | ||
| Pubmed | 1.00e-06 | 64 | 41 | 4 | 22261194 | ||
| Pubmed | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. | 1.02e-06 | 17 | 41 | 3 | 24189052 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7513696 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 8827451 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.36e-06 | 2 | 41 | 2 | 23272068 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31030254 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24799499 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.36e-06 | 2 | 41 | 2 | 27729120 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 34058148 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 37146737 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.36e-06 | 2 | 41 | 2 | 23527003 | |
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.36e-06 | 2 | 41 | 2 | 14988081 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 16540890 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15563276 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 36111525 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17621824 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24317696 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.36e-06 | 2 | 41 | 2 | 27845589 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22391959 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.36e-06 | 2 | 41 | 2 | 35776514 | |
| Pubmed | Midkine gene and the m4 muscarinic acid receptor gene are linked on mouse chromosome 2. | 1.36e-06 | 2 | 41 | 2 | 8921396 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 27435107 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24327612 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26871672 | ||
| Pubmed | Novel ADAMTSL4 gene mutations in Chinese patients with isolated ectopia lentis. | 1.36e-06 | 2 | 41 | 2 | 35042684 | |
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.36e-06 | 2 | 41 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.36e-06 | 2 | 41 | 2 | 36427316 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26459514 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.36e-06 | 2 | 41 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.36e-06 | 2 | 41 | 2 | 11587997 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.36e-06 | 2 | 41 | 2 | 28607090 | |
| Pubmed | Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype "Acral FibroChondroMyxoid Tumors". | 1.36e-06 | 2 | 41 | 2 | 32047233 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.36e-06 | 2 | 41 | 2 | 24332705 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12514189 | ||
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 1.36e-06 | 2 | 41 | 2 | 34656442 | |
| Pubmed | 1.52e-06 | 71 | 41 | 4 | 33541421 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 4.06e-06 | 3 | 41 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 4.06e-06 | 3 | 41 | 2 | 27602762 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 286744 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27776277 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 4.06e-06 | 3 | 41 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 4.06e-06 | 3 | 41 | 2 | 24577894 | |
| Pubmed | APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G. | 4.06e-06 | 3 | 41 | 2 | 27289067 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24698729 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24725948 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 4.06e-06 | 3 | 41 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 4.06e-06 | 3 | 41 | 2 | 23533681 | |
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 4.06e-06 | 3 | 41 | 2 | 34158522 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20702647 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 1541833 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27356895 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23315078 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20980520 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 4.06e-06 | 3 | 41 | 2 | 25589647 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 284359 | ||
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 4.06e-06 | 3 | 41 | 2 | 29604272 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29286856 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20617165 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31801862 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 11579105 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 4.06e-06 | 3 | 41 | 2 | 39208378 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31943071 | ||
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 4.06e-06 | 3 | 41 | 2 | 19596978 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 4.06e-06 | 3 | 41 | 2 | 31518043 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 4.06e-06 | 3 | 41 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 4.06e-06 | 3 | 41 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 4.06e-06 | 3 | 41 | 2 | 25505062 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31595054 | ||
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 4.06e-06 | 3 | 41 | 2 | 24840555 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 4.06e-06 | 3 | 41 | 2 | 17967065 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 36675209 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17012248 | ||
| Pubmed | The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. | 4.06e-06 | 3 | 41 | 2 | 23001005 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20335265 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31520477 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 4.06e-06 | 3 | 41 | 2 | 29593034 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23710953 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 3.53e-04 | 153 | 41 | 3 | chr11p11 | |
| Cytoband | 11p11.2 | 2.53e-03 | 83 | 41 | 2 | 11p11.2 | |
| Cytoband | 22q13.1 | 2.65e-03 | 85 | 41 | 2 | 22q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 3.21e-03 | 330 | 41 | 3 | chr22q13 | |
| Cytoband | 11p15.5 | 5.03e-03 | 118 | 41 | 2 | 11p15.5 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.69e-08 | 19 | 31 | 4 | 50 | |
| GeneFamily | ADAMTS like | 1.59e-07 | 7 | 31 | 3 | 947 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 9.94e-07 | 12 | 31 | 3 | 406 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 1.45e-05 | 28 | 31 | 3 | 745 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.58e-04 | 161 | 31 | 4 | 593 | |
| GeneFamily | CD molecules|Mucins | 5.85e-04 | 21 | 31 | 2 | 648 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.69e-03 | 163 | 31 | 3 | 590 | |
| Coexpression | NABA_MATRISOME | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 MUC5B ADAMTSL1 ISM2 MDK ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON CLEC4C LPA | 4.89e-14 | 1008 | 41 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS16 ADAMTS10 ADAMTS20 PAPLN SEMA5A THBS1 MUC5B ADAMTSL1 ISM2 MDK ADAMTS9 SSPOP MUC5AC ADAMTSL4 SBSPON CLEC4C LPA | 6.52e-14 | 1026 | 41 | 17 | M5889 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A MUC5B ADAMTSL1 ISM2 MDK ADAMTS9 MUC5AC ADAMTSL4 CLEC4C LPA | 5.36e-11 | 738 | 41 | 13 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS16 ADAMTS10 ADAMTS20 SEMA5A MUC5B ADAMTSL1 ISM2 MDK ADAMTS9 MUC5AC ADAMTSL4 CLEC4C LPA | 6.65e-11 | 751 | 41 | 13 | M5885 |
| Coexpression | NABA_ECM_REGULATORS | 8.05e-08 | 238 | 41 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 9.02e-08 | 242 | 41 | 7 | MM17062 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.08e-04 | 158 | 41 | 4 | MM17063 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP | 1.09e-04 | 59 | 41 | 3 | M15844 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.43e-04 | 170 | 41 | 4 | M5880 | |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_DN | 2.13e-04 | 74 | 41 | 3 | M17535 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.24e-04 | 191 | 41 | 4 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.47e-04 | 196 | 41 | 4 | M3008 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 2.62e-04 | 199 | 41 | 4 | M6645 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | 2.72e-04 | 201 | 41 | 4 | MM17086 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 167 | 41 | 5 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-07 | 169 | 41 | 5 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-07 | 177 | 41 | 5 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.29e-07 | 179 | 41 | 5 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 6.83e-07 | 182 | 41 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 7.60e-07 | 186 | 41 | 5 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-07 | 187 | 41 | 5 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.44e-07 | 190 | 41 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.44e-07 | 190 | 41 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-07 | 191 | 41 | 5 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-07 | 191 | 41 | 5 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.89e-07 | 192 | 41 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-07 | 193 | 41 | 5 | 3a9fe4e709c09ec787c71bdd6b58a71c419896de | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-07 | 193 | 41 | 5 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 198 | 41 | 5 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 199 | 41 | 5 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 200 | 41 | 5 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.55e-06 | 145 | 41 | 4 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 157 | 41 | 4 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.37e-05 | 159 | 41 | 4 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 164 | 41 | 4 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 165 | 41 | 4 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 165 | 41 | 4 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.67e-05 | 167 | 41 | 4 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.71e-05 | 168 | 41 | 4 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 170 | 41 | 4 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.87e-05 | 172 | 41 | 4 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-05 | 174 | 41 | 4 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-05 | 175 | 41 | 4 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-05 | 175 | 41 | 4 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-05 | 175 | 41 | 4 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 177 | 41 | 4 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 177 | 41 | 4 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 177 | 41 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 177 | 41 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 177 | 41 | 4 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 178 | 41 | 4 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-05 | 178 | 41 | 4 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 178 | 41 | 4 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-05 | 179 | 41 | 4 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.19e-05 | 179 | 41 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-05 | 180 | 41 | 4 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 2.28e-05 | 181 | 41 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-05 | 181 | 41 | 4 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-05 | 181 | 41 | 4 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-05 | 182 | 41 | 4 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 2.38e-05 | 183 | 41 | 4 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 183 | 41 | 4 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 183 | 41 | 4 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 184 | 41 | 4 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 184 | 41 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 41 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 185 | 41 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.49e-05 | 185 | 41 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 185 | 41 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 41 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 2.49e-05 | 185 | 41 | 4 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | control-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-05 | 186 | 41 | 4 | fe31e9cf4575ee40b50489593c51d8c36c3cc532 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.54e-05 | 186 | 41 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-05 | 186 | 41 | 4 | fccee4cfcc887358cf916d974f29627095b5ad9c | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 2.54e-05 | 186 | 41 | 4 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-05 | 186 | 41 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 187 | 41 | 4 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 41 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.59e-05 | 187 | 41 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 187 | 41 | 4 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.65e-05 | 188 | 41 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | NS-critical-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-05 | 188 | 41 | 4 | 6ee2e7fa80f48e4a7f3321b0776a4f697469bc61 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-05 | 188 | 41 | 4 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 189 | 41 | 4 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.71e-05 | 189 | 41 | 4 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.71e-05 | 189 | 41 | 4 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.71e-05 | 189 | 41 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-05 | 189 | 41 | 4 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.76e-05 | 190 | 41 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-05 | 190 | 41 | 4 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 190 | 41 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.76e-05 | 190 | 41 | 4 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-05 | 190 | 41 | 4 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.76e-05 | 190 | 41 | 4 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-05 | 190 | 41 | 4 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 190 | 41 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.82e-05 | 191 | 41 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 192 | 41 | 4 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.88e-05 | 192 | 41 | 4 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 192 | 41 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 192 | 41 | 4 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-G_(Club-Clara_cells)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.88e-05 | 192 | 41 | 4 | c7c232545fad8ad327ab94bd0def8dc5daacd03d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.88e-05 | 192 | 41 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| Drug | angiogenesis inhibitor | 3.31e-06 | 128 | 41 | 5 | CID002812173 | |
| Drug | chondroitin sulfate | 8.11e-06 | 413 | 41 | 7 | CID000024766 | |
| Drug | AC1NX069 | 2.59e-05 | 32 | 41 | 3 | CID005716906 | |
| Drug | ABT510 | 2.59e-05 | 32 | 41 | 3 | CID006918562 | |
| Disease | interstitial lung disease | 2.09e-06 | 67 | 40 | 4 | EFO_0004244 | |
| Disease | scoliosis (implicated_via_orthology) | 1.79e-05 | 5 | 40 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 7.86e-05 | 61 | 40 | 3 | DOID:3587 (is_marker_for) | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 8.01e-05 | 10 | 40 | 2 | EFO_0801544 | |
| Disease | cholangiocarcinoma (is_marker_for) | 9.08e-05 | 64 | 40 | 3 | DOID:4947 (is_marker_for) | |
| Disease | pulmonary fibrosis | 9.78e-05 | 11 | 40 | 2 | EFO_0009448 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 1.17e-04 | 12 | 40 | 2 | EFO_0008284 | |
| Disease | body fat distribution | 1.61e-04 | 202 | 40 | 4 | EFO_0004341 | |
| Disease | susceptibility to pneumonia measurement | 3.11e-04 | 97 | 40 | 3 | EFO_0008410 | |
| Disease | saturated fatty acids to total fatty acids percentage | 3.70e-04 | 21 | 40 | 2 | EFO_0022305 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 5.70e-04 | 26 | 40 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | COVID-19 symptoms measurement | 1.04e-03 | 35 | 40 | 2 | EFO_0600019 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.33e-03 | 160 | 40 | 3 | DOID:5844 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement | 2.00e-03 | 1345 | 40 | 7 | EFO_0010736 | |
| Disease | linoleic acid measurement | 2.05e-03 | 186 | 40 | 3 | EFO_0006807 | |
| Disease | idiopathic pulmonary fibrosis | 2.73e-03 | 57 | 40 | 2 | EFO_0000768 | |
| Disease | obesity (implicated_via_orthology) | 3.09e-03 | 215 | 40 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 3.22e-03 | 62 | 40 | 2 | DOID:1485 (is_marker_for) | |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.60e-03 | 227 | 40 | 3 | EFO_0004346, EFO_0010736 | |
| Disease | rheumatoid arthritis (is_marker_for) | 3.97e-03 | 69 | 40 | 2 | DOID:7148 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CQSCIPDTVWSIGYW | 426 | P08173 | |
| NYEVTWYTSWSPCPE | 281 | Q96AK3 | |
| WYTSWSPCPECAGEV | 286 | Q96AK3 | |
| TPCPPYWEAGEWTSC | 721 | Q6UY14 | |
| ISWSPCFSWGCAGEV | 96 | P31941 | |
| WCVSRSCPEPEYVWT | 251 | Q2WEN9 | |
| PEWAALDWSECTPSC | 946 | Q9H324 | |
| ACPPSWSVGNWSACS | 926 | Q8TE57 | |
| NGEWGPWEPYSSCSR | 556 | P59510 | |
| TGCEPQCAWSEWLDY | 4126 | Q9HC84 | |
| PPYSPIYTSWIDCWC | 256 | Q9Y6C9 | |
| WVDCESPDLYPVGWC | 536 | Q05BQ5 | |
| ECAEWAWGPCTPSSK | 36 | P21741 | |
| AWYPAQWQPCSRTCG | 731 | Q8N6G6 | |
| EWSPWSPCSGNCSTG | 331 | Q6H9L7 | |
| LCTWTEWIDGSYPAP | 1581 | P98088 | |
| PDTYPSDWSEVTCWQ | 196 | Q9HC73 | |
| IFSSAWWVPPCCGTA | 66 | Q9Y5U4 | |
| VTWYTSWSPCPECAG | 271 | Q8IUX4 | |
| PCEYVWITGEWSECS | 1611 | Q9P2N4 | |
| VPCPSYLPWWSEESS | 116 | O95838 | |
| SGYWWCPKAETTPSG | 281 | Q6V1X1 | |
| AAPWCYTTDPSVRWE | 996 | P08519 | |
| NDGCLWWSPCTPFTE | 311 | P19235 | |
| TLYAWEGACVWIPCT | 31 | P20273 | |
| TCQWDLSWSSDPPFC | 786 | Q9BYH1 | |
| SGPCPEECVWSSWSS | 4361 | A2VEC9 | |
| CPVLGPWSAWSSCSA | 4766 | A2VEC9 | |
| PCATYGWRTTEWTEC | 421 | Q9UPZ6 | |
| SPWSAWGPCTYENCN | 516 | Q9UPZ6 | |
| CVLVPCSFSYPWRSW | 36 | O15389 | |
| DTYTCLCPETWTGWD | 296 | Q99466 | |
| WTSWSPCSTTCGIGF | 601 | Q13591 | |
| NEIWCSCETGYGWPR | 116 | Q8IZF2 | |
| DIEDWSCCPTPWTSF | 76 | Q8WTT0 | |
| WSPWSSCSVTCGDGV | 441 | P07996 | |
| FVGEWSPWSGCADQC | 76 | Q8IVN8 | |
| AWSPEPWGECSVSCG | 426 | O95428 | |
| CLWACTSGYRPETWA | 181 | I3L0S3 | |
| SPMPWLCACGAEWYH | 296 | Q8IYW5 | |
| PCPFDCKLSDWSSWG | 996 | Q9C0I4 | |
| CPVTPCYSWVLGNWS | 1296 | Q9C0I4 | |
| PCPGDCHLTEWSEWS | 1366 | Q9C0I4 | |
| GPEDYWCQCVAWSSA | 136 | O95185 | |
| CVLVPCSFSYPWRSW | 36 | Q08ET2 | |
| GSGVTDCWACFAEPW | 186 | P30518 |